FDA Investigator Jonathan R Campos

Jonathan R Campos has conducted inspections on 193 sites in 8 countries as of 01 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
193
Last Inspection Date:
01 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100008600
Countries of Inspections:
United States of America, Serbia, France, Germany, Romania, Czechia, Australia, Canada
FDA Investigators that have inspected at least one site in common with Jonathan R Campos:
Adree N Anderson, Adrienne Morgan, Alanna L Mussawwir Bias, Alexandra B Pitkin, Alicia M Frees, Althea A Williams, Alysia C Alger, Amanda S Zorn, Anders W Evenson, Andrea A Branche, Andrew A Hoopes, Annette Melendez, Anthony R Bucks, Ashlee M Ward, Ashley A Mutawakkil, Avery J Dennis, Barbara I Rogolsky, Barbara J White, Bei Y He, Betty Kay Baxter, Bonnie E Pierson, Brent T Hall, Brett R Havranek, Brittany D Phillips, Brittany D Terhar, Bruce E Taylor, Brunilda Torres, Candace S Tucker, Carl J Montgomery, Carmen Y Fisher, Caroline H Le, Catherine R Olguin, Chad W Rice, Charles R Cote, RIC, Chilton L Ng, Chris A Sack, Christine I Shaw, Christine M Parmentier, Christopher A Hairr, Cody D Rickman, Cody J Alley, Collins M Mason, Courtney R Bratina, Cynthia Jim, CSO, Cynthia L Evitt, Cynthia L Gorveatt, Cynthia M Goudeau, Dana D Carter, SR DDS, Dana J Monroe, Danial S Hutchison, Daniel J Lahar, Daniel Pst Laurent, Darrah, David L Miser, Dawn C Olenjack, Deidre R Edwards, Denise L Burosh, Diana K Krepel, Dianna D Wardlow Dotter, Dina K West, Dolores Harper, Douglas A Campbell, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dwight D Ferguson, Dylan D Yao, MD, PhD, Edward E Lockwood (EEL), Eileen A Liu, Elizabeth D Gonzales, Elizabeth S Howell, Emily A Baldwin, Emily A Green, Eric C Fox, Eric C Nielsen, Eric M Mueller, PharmD, Eric M Padgett, Eric T Huebler, Erika V Butler, Erin C Dugan, Erin M Mcdowell, Esther A Ofori, Farhana Khan, George Ivan Wey, Gerardo A Ramirez, Ginger M Sykes, Gloria A Milster, Hanna L Potter, Hasan A Irier, PhD, Heath W Cartwright, Himanshu Gupta, PhD, Hiwot A Kesi, Huffmanc, Isabel Y Espinosa, Isatu N Bah, Ismael Garibay, Jacob W Reynolds, James D Planchon, James I Giefer, James J Houlihan, James P Mcreavey, Jamie L Dion, Jane E Nelson, Janesa A Licorish, Janet Pulver, Janete A Eaker, Janete A Oliveira, Janna C Hutchinson, Jasjeet K Sekhon, Jeanne J Thai, Jeffery A Hangartner, Jeffrey B Moody, Jeffrey W Shrifter, DPM, Jennifer A Baker, Jessica E Hensley, Jessica L Peterson, Joan T Briones, Joanne T Rupprecht, John A Iwen, John W Banks, Johnson, Joseph R Lambert, Julie N Vosilus, Justin A Boyd, Jyoti B Patel, PhD, Kaitlyn T Dang, Kara L Roden, Karen C Daugherty, Karen M Cooper, Karen M Montgomery (KMM), Katherine M Taylor, Kathleen B Swat, Kathleen J Close, Kathleen J Klier, Kathleen S Tormey, Kathryn A Bushur, Kellia N Hicks, Kelly D Moore, Kelly D Sheppard, Kimberlee A Ewing, Kimberley A Hoefen, Kimetha A King, Kristi B Panzer, Kristi M Hampton Thurston, Latonya M Mitchell, Latrice G Jones, Laura B Kennedy, Lavender M Huskey, LCDR Angelica M Chica, LCDR Ismael Olvera, IV, LCDR Matthew J Morrison, Linda F Murphy, Linda K Cline, Linda M Cheny, Linda R Kuchenthal, Linhart, Lionell L Thomas, Lisa D Ellis, Lisa L Flores, Lisa L Gilliam, Logan M Jones, Lori A Gioia, Lori B Wikstrom, Louis S Chen, LT Mark A Chen, MPH, LT Richard A Lyght, Lyndsey G Smith, Makini Cobourne Duval, PhD, Marc A Jackson, Jr, Marcus F Yambot, Marion W Nadeau, Mark E Chan, Mary K Concannon, Matthew A Walburger, Matthew F Duff, Matthew M Schuckmann, Matthew M Vernon, Matthew P Barnard, Matthew R Dionne, Meisha Waters, Melinda L Rice, Melissa M Steiger, Melva J Palmer, Meredith M Cobb, Michael A Feingold, Michael F Skelly, PhD, Michael R Goga, Michael S Kopf, Michele L Obert, Michele Perry Williams, Minerva Rogers, Miranda D Mcdonald, Mitzi A Schwertfeger, Mohsen Rajabi Abhari, FDA, Monica M Mcclure, Nadine Nanko Johnson, Nancy G Schmidt, Naseem S Jouhari, Nathan R Moon, Ngoc B Kelsch, Nia K Walker, Nicholas Z Lu, Nicole J Clausen, Nicole J Conklin, Nilufer M Tampal, PhD, Paige E Shelborne, Pamela L Velez Vega, Patricia A Brown, Patricia D Stahnke, Patrick L Wisor, Patrick S Price, Paul F Rader, Peter E Gruman, Peter T Regan, Philip E Ake, Rashonda N Rucker, Raymond H Price, Rebecca T Davis, Richard D Coleman, Richard L Rutherford, Ricki A Chase, Rita K Kabaso, Robert J Ham, Robert J Nesselhauf, Robert S Woodruff, Robin E Hayes, Rodney D Combs, Ronda Rloyd Jones, Rose Xu, Rowena S Nguyen, Ruben C Ayala, PharmD, Ruth A Williams, Samson O Oluseye, Samuel K Gibbons, Jr, Sandra A Hughes, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah E Morris, Sarah E Rhoades, Scott A Jepson, Scott B Laufenberg, Shafiq S Ahadi, Shanna R Haden, Shaun M Olson, Shaun M Stracener, Shawn B Johnson, Sheri L Stephenson, Shwnji Susie Lee, Srinivas R Chennamaneni, PhD, Stacey F Rivette, Stephanie L Shapley, Stephen T Hansen, Steve P Yost, Steven C Clifford, Steven D Kehoe, Steven P Allen, Stroman, Sunitha K Rajaram, PhD, Susan L Young, Susanna E Ford, Susie H Lee, Tamara J Umscheid, Tamara L Setzer, Tara M Aikens, Teena H Aiken, Thai T Duong, Thao T Kwan, Theresa C Klaman, Theressa B Smith, Thomas R Beilke, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy C Grome, Timothy D Evans, Tristian E Strait, Veronica Fuentes, MS, Vickie J Kanion, Victoria A Wagoner, Walsworth, Warren J Lopicka, Weston K Szymanski, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yiyue Zhang (nmi), PhD, Zachary A Bogorad, Zachary L Stamm

Jonathan R Campos's Documents

Publish Date Document Type Title
October, 2015 EIR Remel, Inc - EIR, 2015-10-23
July, 2014 FDA 483 Remel, Inc - Form 483, 2014-07-03
August, 2023 FDA 483 Mimi Liu, MD - Form 483, 2023-08-18
October, 2015 FDA 483 Response Remel, Inc - Form 483R, 2015-11-06
March, 2021 EIR OPKO Health, Inc. - EIR, 2021-03-01
January, 2013 EIR Apria Healthcare Inc dba Knoll Patient Supply - EIR, 2013-01-09
November, 2018 EIR Melamed, Isaac R. , M.D. - EIR, 2018-11-08
September, 2015 FDA 483 Psi Health Solutions, Inc. - Form 483, 2015-09-09
June, 2018 FDA 483 Esoterix Clinical Trials Services - Form 483, 2018-06-27
June, 2018 FDA 483 Response Esoterix Clinical Trials Services - Form 483R, 2018-07-11
July, 2021 FDA 483 Redbeast Enterprises Inc dba High Quality Research - Form 483, 2021-07-29
May, 2019 FDA 483 Brian R. Davis, MD - Form 483, 2019-05-16
January, 2020 FDA 483 Response Lovelace Biomedical Research Institute - Form 483R, 2020-02-20
July, 2021 FDA 483 Veterinary & Biomedical Research Center, Inc. - Form 483, 2021-07-01
July, 2015 FDA 483 Central Solutions Inc - Form 483, 2015-07-10
March, 2013 EIR Pro-Pet LLC - EIR, 2013-03-01
November, 2018 FDA 483 Frei, Donald MD - Form 483, 2018-11-01
November, 2019 FDA 483 SCL Health IRB - Form 483, 2019-11-07
June, 2018 EIR Esoterix Clinical Trials Services - EIR, 2018-09-11
July, 2021 FDA 483 Response Redbeast Enterprises Inc dba High Quality Research - Form 483R, 2021-07-29
July, 2014 EIR Remel, Inc - EIR, 2014-07-03
May, 2018 EIR PPD Development, L.P. - EIR, 2018-05-18
January, 2018 FDA 483 Frank Dinenno - Form 483, 2018-01-23
August, 2019 FDA 483 Samuel A. Mujica Trenche, MD - Form 483, 2019-08-09
May, 2018 FDA 483 Response PPD Development, L.P. - Form 483R, 2018-06-05
July, 2017 EIR David Miklos, MD - EIR, 2017-07-27
May, 2018 FDA 483 PPD Development, L.P. - Form 483, 2018-05-18
August, 2019 EIR Samuel A. Mujica Trenche, MD - EIR, 2019-08-09
January, 2013 FDA 483 Apria Healthcare Inc dba Knoll Patient Supply - Form 483, 2013-01-09
July, 2021 EIR Redbeast Enterprises Inc dba High Quality Research - EIR, 2021-07-26
January, 2020 FDA 483 Lovelace Biomedical Research Institute - Form 483, 2020-01-31
February, 2023 FDA 483 Immunity Bio, Inc - Form 483, 2023-02-10
October, 2015 FDA 483 Remel, Inc - Form 483, 2015-10-23
February, 2015 FDA 483 Medical Solutions International, Inc. - Form 483, 2015-02-20
January, 2020 EIR Lovelace Biomedical Research Institute - EIR, 2020-01-31
January, 2013 FDA 483 Dyna-Tek Industries - Form 483, 2013-01-24
September, 2015 FDA 483 Chalgren Enterprises, Inc. - Form 483, 2015-09-03
July, 2024 FDA 483 Peet John J MD - Form 483, 2024-07-16
September, 2024 FDA 483 Nostrum Laboratories, Inc. - Form 483, 2024-09-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more